MARKET NEWS

Cadent Therapeutics Secures $40 Million Series B Financing to Advance Pipeline
Provectus Biopharmaceuticals Provides Drug Development Update
Synteract Acquires Pediatric CRO to Further Strengthen its Pediatric Center of Development
Fujifilm Announces Research Results for Novel Liposome Drug Candidate
Aptinyx Exploratory Clinical Studies Provide First Evidence that NYX-2925 Elicits Rapid, Persistent, NMDAr-Mediated Pharmacodynamic Activity in Humans
Commercial Prospects for Immuno-Oncology Development Across Oncology Indications in Untapped Cancer Types or in Combinations

  FEATURED EDITORIAL

  COMPANY PROFILE

Thank you to all of our 2018 partners featured in our Nov/Dec 2018 Company Profiles & Capabilities issue!

 

ABITEC Corporation
Ajinomoto Bio-Pharma Services
Alcami
Ascendia Pharmaceuticals
Avista Pharma Solutions
BASF Corporation
Baxter BioPharma Solutions
BD Medical – Pharmaceutical Systems
BioDuro
Capsugel – Lonza
Captisol, a Ligand Company
Catalent Pharma Solutions
CordenPharma International
CPhI North America
Credence MedSystems, Inc
Croda Health Care
Drug Delivery Experts
Enable Injections
Evonik Industries AG
Exelead
Frontage
Gateway Analytical LLC

 

Gattefosse
Hovione
JRF Global
Lonza Pharma & Biotech
Metrics Contract Services
MilliporeSigma
Mitsubishi Gas Chemical Company, Inc.
Nemera
Noble
PCI Pharma Services
Pfanstiehl
Pfizer CentreOne
PharmaCircle
Portal Instruments
ProMed Pharma, LLC
SGS Life Sciences
SGW Pharma Marketing
SHL Group
UPM Pharmaceuticals
Vetter Pharma International
West Pharmaceutical Services

 

 

  EXCLUSIVE ONLINE CONTENT

Catalent to Open Second Clinical Supply Facility; Enables Broader Integrated Solutions for Global & Local Customers

Catalent to Open Second Clinical Supply Facility; Enables Broader Integrated Solutions for Global & Local Customers

Catalent Pharma Solutions recently announced its plans to invest $2.5 million in a new, second clinical supply facility in Shanghai, China, due to open in early 2019. When completed, the facility is expected to employ 100 people and will double Catalent’s total clinical storage capacity in China.

PCI Clinical Services Announces Site Expansion to Support Growth & Flexibility

PCI Clinical Services Announces Site Expansion to Support Growth & Flexibility

PCI Pharma Services, a full-service provider of specialist outsourced drug manufacturing, clinical trial services, and commercial packaging to the global biopharmaceutical industry, recently announced the expansion of its Clinical site at Rockford, IL.

Enable Injections Enters Strategic Partnerships With UCB & Apellis

Enable Injections Enters Strategic Partnerships With UCB & Apellis

Enable Injections, Inc., a patient-centric drug delivery combination product company developing advanced wearable devices for subcutaneous delivery of high-volume therapeutics, recently announced it has entered into development agreements with Apellis Pharmaceuticals, and most recently, UCB.

Nemera’s e-Novelia® Ophthalmic Add-On Wins “Excellence in Pharma: Drug Delivery Devices” Award

Nemera’s e-Novelia® Ophthalmic Add-On Wins “Excellence in Pharma: Drug Delivery Devices” Award

A team of industry experts awarded Nemera’s electronic add-on for ophthalmic droppers with a prestigious CPhI Award for Best Drug Delivery Device in its category.

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

November 28 – Polymers & Biomaterials
December 5 – Capsules